Gastric sleeve
The gastric sleeve is a safe and effective procedure that reduces the size of the stomach and promotes better control of food intake and appetite through hormonal changes related to satiety.
Gastric sleeve
The gastric sleeve (sleeve gastrectomy) it is a laparoscopic surgery in which it is permanently removed ~75–85% of the stomach, leaving a reservoir narrower and tube-shaped. This helps to eat less, reduce appetite and improvement glucose control through hormonal changes, without intestinal bypass.
Health benefits
Gastric sleeve: evidence and efficacy
Gastric sleeve surgery is backed by clinical evidence: it achieves lasting weight loss, improves metabolic health and reduces comorbidities, with a positive impact on quality of life.
Backed by clinical evidence
Type 2 diabetes
It improves glycaemic control, but long-term remission is usually lower than with gastric bypass
OSEBERG RCTLancet Diabetes Endocrinol, 2025
Weight loss
Clinically significant and sustained weight loss, superior to intensive medical treatment
STAMPEDE RCTNEJM, 2017
Blood pressure
Improve control and reduce medication use, remission is usually greater with gastric bypass
The SLEEVEPASS RCTJAMA, 2024
Liver health (MASH)
Higher probability of histological resolution without worsening fibrosis vs lifestyle alone
BRAVES RCTLancet, 2023
Dyslipidaemia
It improves triglycerides and HDL, and the decrease in LDL cholesterol is usually greater with gastric bypass
OSEBERG RCTLancet Diabetes Endocrinol, 2025
GORD (reflux)
It increases the risk of onset or worsening; if reflux is significant, gastric bypass is preferred.
SM-BOSS RCTJAMA, 2018
Sleep Apnoea
Improvement or remission is frequent, and is similar in the long term compared to gastric bypass
SLEEVEPASS – SM-BOSS RCTBritish Journal of Surgery, 2020
Nutritional security
Fewer late major complications than with bypass in long-term trials
SLEEVEPASS RCTJAMA, 2018
The gastric sleeve is one of the most thoroughly researched bariatric procedures, backed by high-quality clinical trials and long-term scientific evidence
Which bariatric option is right for you?
Results vary depending on your health, habits and adherence to the treatment plan.
| Comparison | Gastric bypass | Gastric sleeve | Gastric band | Gastric balloon |
|---|---|---|---|---|
| Ideal for | BMI ≥ 35 with comorbidities or gastro-oesophageal reflux | BMI ≥ 35 with associated comorbidities | Obesity with comorbidities | BMI ≥ 27 with any comorbidity |
| Main objective | Weight loss and metabolic control | Weight loss and metabolic control | Weight loss | Weight loss and lifestyle change |
| Average weight loss | 32.8% TBWL | 28.9% TBWL | 17.3% TBWL | 15% TBWL (Spatz3 balloon) |
| Inpatient care | 1 day | 1 day | Same-day discharge | Same-day discharge |
| Return to activities | 1 week | 1 week | 1 week | 3 days |
| Duration | Permit | Permit | Adjustable and reversible | Temporary (4–12 months) |
| Important aspects | Greater type 2 diabetes remission and improvement in reflux | No bowel bypass • Reflux may appear or worsen | Reversible • Requires adjustments | Non-surgical • Endoscopic or via ingestible capsule |
Gastric bypass
- Ideal for
- BMI ≥35 with associated comorbidities or GORD
- Main objective
- Weight loss + metabolic control
- Average weight loss
- 32.8% TBWL
- Inpatient care
- 1 day
- Return to activities
- 1 week
- Duration
- Permit
- Important aspects
- Greater remission of type 2 diabetes • Improvement of GORD
Gastric sleeve
- Ideal for
- BMI ≥35 with associated conditions
- Main objective
- Weight loss + metabolic control
- Average weight loss
- 28.9% TBWL
- Inpatient care
- 1 day
- Return to activities
- 1 week
- Duration
- Permit
- Important aspects
- • No intestinal diversion • GORD may appear or worsen
Gastric band
- Ideal for
- Obesity with comorbidities
- Main objective
- Weight loss
- Average weight loss
- 17.3% TBWL
- Inpatient care
- Same-day discharge
- Return to activities
- 1 week
- Duration
- Adjustable and reversible
- Important aspects
- Reversible • Requires adjustments
Gastric balloon
- Ideal for
- BMI ≥27 with one comorbidity
- Main objective
- Weight loss and lifestyle change
- Average weight loss
- 15% TBWL (Spatz3 balloon)
- Inpatient care
- Same-day discharge
- Return to activities
- 3 days
- Duration
- Temporary (4–12 months)
- Important aspects
- Non-surgical • Endoscopic or via ingestible capsule
Ready to take the next step?
Speak with our bariatric surgery specialists.
Our patient results
Thousands of patients have trusted Dr Dick Manrique and his multidisciplinary team to transform their health, regain their confidence and improve their quality of life.
¿Qué procedimiento necesita?
Los resultados pueden variar según la condición médica, el peso, el estilo de vida y la adherencia al tratamiento.
| Comparison | Gastric bypass | Gastric sleeve | Gastric band | Gastric balloon |
|---|---|---|---|---|
| Ideal for | BMI ≥35 with associated comorbidities or GORD | BMI ≥35 with associated conditions | Obesity with comorbidities | BMI ≥27 with one comorbidity |
| Main objective | Weight loss + metabolic control | Weight loss + metabolic control | Weight loss | Pérdida de peso a corto plazo + cambio de hábitos |
| Pérdida de peso esperada | ≥30% TBWL | 25–29.9% TBWL | 15–19.9% TBWL | <15% TBWL (Spatz3 balloon) |
| Inpatient care | 1 day | 1 day | Same-day discharge | Same-day discharge |
| Return to activities | 1 week | 1 week | 1 week | 3 days |
| Duration | Permit | Permit | Adjustable and reversible | Temporary (4–12 months) |
| Important aspects | Greater remission of type 2 diabetes • Improvement of GORD | • No intestinal diversion • GORD may appear or worsen | Reversible • Requires adjustments | Non-surgical • Endoscopic or via ingestible capsule |
Gastric bypass
- Ideal for
- BMI ≥35 with associated comorbidities or GORD
- Main objective
- Weight loss + metabolic control
- Pérdida de peso esperada
- ≥30% TBWL
- Inpatient care
- 1 day
- Return to activities
- 1 week
- Duration
- Permit
- Important aspects
- Greater remission of type 2 diabetes • Improvement of GORD
Gastric sleeve
- Ideal for
- BMI ≥35 with associated conditions
- Main objective
- Weight loss + metabolic control
- Pérdida de peso esperada
- 25–29.9% TBWL
- Inpatient care
- 1 day
- Return to activities
- 1 week
- Duration
- Permit
- Important aspects
- • No intestinal diversion • GORD may appear or worsen
Gastric band
- Ideal for
- Obesity with comorbidities
- Main objective
- Weight loss
- Pérdida de peso esperada
- 15–19.9% TBWL
- Inpatient care
- Same-day discharge
- Return to activities
- 1 week
- Duration
- Adjustable and reversible
- Important aspects
- Reversible • Requires adjustments
Gastric balloon
- Ideal for
- BMI ≥27 with one comorbidity
- Main objective
- Pérdida de peso a corto plazo + cambio de hábitos
- Pérdida de peso esperada
- <15% TBWL (Spatz3 balloon)
- Inpatient care
- Same-day discharge
- Return to activities
- 3 days
- Duration
- Temporary (4–12 months)
- Important aspects
- Non-surgical • Endoscopic or via ingestible capsule
Ready to take the next step?
Speak with our bariatric surgery specialists.
From the first appointment to post-bariatric care
His process goes beyond the procedure: comprehensive initial assessment and long-term multidisciplinary follow-up to sustain his progress and well-being
First appointment and assessment
Evaluate your case with Dr Dick Manrique's team to define your goals, clarify any questions and explore your treatment options
Personalised plan
Every patient is unique. We design a plan tailored to your health profile, lifestyle and long-term goals
Bariatric procedure
With an international career and reputation, Dr Dick Manrique performs his procedure with the utmost precision and safety
Continuous monitoring
Lasting results require follow-up; our team will support you after the procedure